Simon Frantz

1.2k total citations
67 papers, 921 citations indexed

About

Simon Frantz is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Simon Frantz has authored 67 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Reproductive Medicine, 17 papers in Public Health, Environmental and Occupational Health and 14 papers in Economics and Econometrics. Recurrent topics in Simon Frantz's work include Science, Research, and Medicine (18 papers), Pharmaceutical Economics and Policy (12 papers) and Biotechnology and Related Fields (11 papers). Simon Frantz is often cited by papers focused on Science, Research, and Medicine (18 papers), Pharmaceutical Economics and Policy (12 papers) and Biotechnology and Related Fields (11 papers). Simon Frantz collaborates with scholars based in United States and United Kingdom. Simon Frantz's co-authors include Karen Birmingham, Paul Smaglik, Adam C. Smith, Peter J. Kirkpatrick and Melanie Brazil and has published in prestigious journals such as Nature, Nature Medicine and Nature Reviews Molecular Cell Biology.

In The Last Decade

Simon Frantz

57 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Frantz United States 12 497 162 137 113 97 67 921
Irena Melnikova United States 13 367 0.7× 117 0.7× 107 0.8× 56 0.5× 180 1.9× 22 919
Tina Garyantes United States 10 734 1.5× 390 2.4× 145 1.1× 73 0.6× 53 0.5× 16 1.3k
Zengtao Wang China 18 437 0.9× 63 0.4× 291 2.1× 105 0.9× 86 0.9× 83 1.1k
Claudia Ruiz United States 20 616 1.2× 126 0.8× 399 2.9× 140 1.2× 54 0.6× 36 1.0k
Alex. M. Weir United Kingdom 2 424 0.9× 371 2.3× 92 0.7× 95 0.8× 32 0.3× 2 956
Θεοδώρα Κάτσιλα Greece 20 614 1.2× 212 1.3× 57 0.4× 132 1.2× 54 0.6× 89 1.4k
R. Nathan Daniels United States 16 880 1.8× 144 0.9× 358 2.6× 143 1.3× 45 0.5× 23 1.4k
Marina Tintelnot‐Blomley Switzerland 17 463 0.9× 249 1.5× 217 1.6× 71 0.6× 222 2.3× 29 879
Jay S. Tung United States 16 981 2.0× 125 0.8× 153 1.1× 328 2.9× 129 1.3× 18 1.3k
Andrea Olland United States 19 509 1.0× 231 1.4× 272 2.0× 109 1.0× 150 1.5× 23 995

Countries citing papers authored by Simon Frantz

Since Specialization
Citations

This map shows the geographic impact of Simon Frantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Frantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Frantz more than expected).

Fields of papers citing papers by Simon Frantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Frantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Frantz. The network helps show where Simon Frantz may publish in the future.

Co-authorship network of co-authors of Simon Frantz

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Frantz. A scholar is included among the top collaborators of Simon Frantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Frantz. Simon Frantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frantz, Simon. (2011). Engineered T-cell therapy shows efficacy in blood cancer. Nature Biotechnology. 29(10). 853–854. 9 indexed citations
2.
Frantz, Simon. (2006). Safety concerns raised over RNA interference. Nature Reviews Drug Discovery. 5(7). 528–529. 9 indexed citations
3.
Frantz, Simon. (2006). Chemistry outsourcing going global. Nature Reviews Drug Discovery. 5(5). 362–363. 5 indexed citations
4.
Frantz, Simon. (2006). 2005 approvals: Safety first. Nature Reviews Drug Discovery. 5(2). 92–93. 4 indexed citations
5.
Frantz, Simon. (2006). Industry sweats after patent verdict. Nature Reviews Drug Discovery. 5(6). 443–444. 2 indexed citations
6.
Frantz, Simon. (2005). How to avoid another 'Vioxx'. Nature Reviews Drug Discovery. 4(1). 5–7. 17 indexed citations
7.
Frantz, Simon. (2005). Dangerous drugs?. Nature. 2 indexed citations
8.
Frantz, Simon. (2005). An array of problems. Nature Reviews Drug Discovery. 4(5). 362–363. 47 indexed citations
9.
Frantz, Simon. (2004). Therapeutic area influences drug development costs. Nature Reviews Drug Discovery. 3(6). 466–466. 8 indexed citations
10.
Frantz, Simon. (2004). Eight steps to silence. Nature Reviews Drug Discovery. 3(3). 204–204. 2 indexed citations
11.
Frantz, Simon. (2003). Creating the right chemistry. Nature Reviews Drug Discovery. 2(2). 163–163. 2 indexed citations
12.
Frantz, Simon. (2003). Choosing a career in private or corporate patent practice. Nature Reviews Drug Discovery. 2(10). 845–845. 1 indexed citations
13.
Frantz, Simon. (2003). Screening the right candidate. Nature Reviews Drug Discovery. 2(4). 331–331. 1 indexed citations
14.
Frantz, Simon, et al.. (2003). Bortezomib. Nature Reviews Drug Discovery. 2(8). 611–612. 198 indexed citations
15.
Frantz, Simon. (2003). In vivo we trust. Nature Reviews Drug Discovery. 2(6). 501–501. 4 indexed citations
16.
Frantz, Simon. (2003). Antidepressant use in children questioned. Nature Reviews Drug Discovery. 2(12). 939–939. 3 indexed citations
17.
Frantz, Simon. (2003). ALLHATs off to the golden oldie. Nature Reviews Drug Discovery. 2(2). 91–91. 7 indexed citations
18.
Smith, Adam C., Melanie Brazil, Peter J. Kirkpatrick, & Simon Frantz. (2002). In this issue. Nature Reviews Drug Discovery. 1(10). 741–741.
19.
Frantz, Simon. (2002). Accentuate the negative. Nature Reviews Molecular Cell Biology. 3(8). 553–553.
20.
Frantz, Simon. (2002). Max Perutz 1914–2002. Nature Reviews Molecular Cell Biology. 3(3). 146–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irena Melnikova Breakdown of academic impact, for papers by Tina Garyantes Breakdown of academic impact, for papers by Zengtao Wang Breakdown of academic impact, for papers by Claudia Ruiz Breakdown of academic impact, for papers by Alex. M. Weir Breakdown of academic impact, for papers by Θεοδώρα Κάτσιλα Breakdown of academic impact, for papers by R. Nathan Daniels Breakdown of academic impact, for papers by Marina Tintelnot‐Blomley Breakdown of academic impact, for papers by Jay S. Tung Breakdown of academic impact, for papers by Andrea Olland
Rankless by CCL
2026